Skip to content
healthcare.dev
Get a free key

Olmesartan medoxomil, amlodipine and hydrochlorothiazide

NDC 31722-895, Olmesartan medoxomil, amlodipine and hydrochlorothiazide, tablet, film coated, from Camber Pharmaceuticals, Inc..

Product NDC
31722-895
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209242
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-895 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLMESARTAN MEDOXOMIL40 mg/1
  • AMLODIPINE BESYLATE10 mg/1
  • HYDROCHLOROTHIAZIDE12.5 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
31722-895-303172208953030 TABLET, FILM COATED in 1 BOTTLE (31722-895-30)
31722-895-323172208953210 BLISTER PACK in 1 CARTON (31722-895-32) / 8 TABLET, FILM COATED in 1 BLISTER PACK (31722-895-31)
31722-895-903172208959090 TABLET, FILM COATED in 1 BOTTLE (31722-895-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/45e975ff-07b1-411a-96ee-a011d1619b1e

  • NADAC price for package 31722089530

    GET /v1/drugs/nadac/31722089530

  • NADAC price for package 31722089590

    GET /v1/drugs/nadac/31722089590

Use it

Look up 31722-895 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-895 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-895. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.